Beam Therapeutics
BEAM
BEAM
193 hedge funds and large institutions have $1.62B invested in Beam Therapeutics in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 79 increasing their positions, 38 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 193 → 193 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $2.05B → $1.62B (-$428M)
Holders
193
Holding in Top 10
1
Calls
$16.4M
Puts
$12.2M
Top Buyers
| 1 | +$25M | |
| 2 | +$20.6M | |
| 3 | +$13.4M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$10.8M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$10.3M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$8.04M | |
| 3 | -$7.53M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$7.26M |
| 5 |
Goldman Sachs
New York
|
-$6.36M |